Quest Diagnostics (DGX) Long-Term Investments (2014 - 2026)

Quest Diagnostics has disclosed Long-Term Investments across 13 years of filings, most recently posting $137.0 million for Q2 2026.

• In Q2 2026, Long-Term Investments rose 0.74% year-over-year to $137.0 million; the TTM figure through Jun 2026 stood at $137.0 million (up 0.74% YoY), while the FY2025 annual figure was $136.0 million, up 10.57% from the prior year.
• Long-Term Investments came in at $137.0 million for Q2 2026 at Quest Diagnostics, up from $134.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $155.0 million in Q1 2022 to a low of $123.0 million in Q4 2024.
• Average Long-Term Investments over 5 years is $134.5 million, with a median of $134.5 million recorded in 2023.
• The largest YoY upside for Long-Term Investments was 32.43% in 2022 against a maximum downside of 70.59% in 2022.
• Over 5 years, Long-Term Investments stood at $132.0 million in 2022, then gained by 2.27% to $135.0 million in 2023, then dropped by 8.89% to $123.0 million in 2024, then gained by 10.57% to $136.0 million in 2025, then climbed by 0.74% to $137.0 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $137.0 million in Q2 2026, $134.0 million in Q1 2026, and $136.0 million in Q4 2025.